Rx EnroMed 100 Injectable Antimicrobial Solution (Enrofloxacin)
Rx EnroMed 100 is a sterile, ready-to-use injectable antimicrobial solution containing enrofloxacin, a broad-spectrum fluoroquinolone antibiotic. It is FDA approved for the treatment and control of bovine respiratory disease (BRD) in cattle and swine respiratory disease (SRD), and for the control of colibacillosis in weaned swine when diagnosed.
Each mL of EnroMed 100 contains 100 mg of enrofloxacin. Excipients include L-arginine base, n-butyl alcohol, benzyl alcohol (as a preservative), and water for injection.
Key Benefits
- Treats and controls bovine respiratory disease (BRD) in cattle
- Treats and controls swine respiratory disease (SRD)
- Controls colibacillosis in weaned swine when diagnosed
- Broad-spectrum fluoroquinolone antimicrobial
- Flexible dosing options for single-dose or multi-day therapy in cattle
- Approved for subcutaneous use in cattle
- Approved for intramuscular or subcutaneous use in swine
- Sterile, ready-to-use injectable solution
- No refrigeration required
- FDA approved prescription medication
Indications
Cattle:
- Treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis in beef and non-lactating dairy cattle
- Control of BRD in beef and non-lactating dairy cattle at high risk of developing disease
Swine:
- Treatment and control of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis, Streptococcus suis, Bordetella bronchiseptica, and Mycoplasma hyopneumoniae
- Control of colibacillosis associated with Escherichia coli in groups or pens of weaned pigs where disease has been diagnosed
Dosage & Administration
Dosage selection and treatment duration should be based on veterinary judgment, pathogen susceptibility, and clinical response. Always follow the prescribing veterinarian’s instructions.
Cattle:
-
Single-Dose Therapy: 7.5–12.5 mg/kg (3.4–5.7 mL per 100 lb) administered subcutaneously
-
Multiple-Day Therapy: 2.5–5 mg/kg (1.1–2.3 mL per 100 lb) administered subcutaneously once daily for up to 5 days
- Do not exceed 20 mL per injection site
Swine:
- Single dose of 7.5 mg/kg (3.4 mL per 100 lb) administered intramuscularly or subcutaneously behind the ear
- Do not exceed 5 mL per injection site
Withdrawal Periods
-
Cattle (Meat & Offal): 28 days
-
Swine (Meat & Offal): 5 days following a single-injection dose
Use Restrictions
- Not for use in calves to be processed for veal
- Not for use in female dairy cattle 20 months of age or older
- Federal law prohibits extra-label use of this drug in food-producing animals
- Use only by or on the order of a licensed veterinarian
Storage Conditions
- Store at 20–25°C (68–77°F); excursions permitted between 15–30°C (59–86°F)
- Protect from direct sunlight
- Do not refrigerate or freeze
- If precipitation occurs due to cold temperatures, warm and shake to redissolve
Important Safety Information
Not for use in humans. Keep out of reach of children. Individuals with a history of hypersensitivity to quinolones should avoid handling this product. Use with caution in animals with known or suspected central nervous system disorders. Injection may cause transient local tissue reactions that could result in trim loss at slaughter.
This product requires a Valid prescription.
Prescription items are NON-RETURNABLE and NON-REFUNDABLE.
Frequently Asked Questions
Is Rx EnroMed 100 FDA approved?
Yes. Rx EnroMed 100 is FDA approved for use in cattle and swine as indicated on the label.
Does EnroMed require a prescription?
Yes. EnroMed is a prescription antimicrobial and must be used by or on the order of a licensed veterinarian.
What is EnroMed used for?
EnroMed is used to treat and control bovine respiratory disease (BRD) in cattle, swine respiratory disease (SRD), and to control colibacillosis in weaned swine when diagnosed.
How does EnroMed work?
EnroMed contains enrofloxacin, a fluoroquinolone antimicrobial that inhibits bacterial DNA replication, helping stop the growth and spread of susceptible bacteria.
What is Bovine Respiratory Disease (BRD)?
Bovine Respiratory Disease (BRD) is a complex respiratory condition affecting the lungs and airways of cattle. It is commonly associated with stressors such as transport, weaning, commingling, or weather changes, combined with viral and bacterial infections. Cattle with BRD may show signs such as coughing, nasal discharge, fever, reduced feed intake, and labored breathing. When bacterial pathogens are involved, antimicrobial therapy may be required under veterinary direction.
What is Swine Respiratory Disease (SRD)?
Swine Respiratory Disease (SRD) refers to respiratory infections in pigs that can involve one or more bacterial pathogens. These infections often affect the lungs and respiratory tract and may be influenced by environmental stress, stocking density, ventilation, and co-infections. Common signs can include coughing, nasal discharge, reduced weight gain, and increased mortality in affected groups.
What is colibacillosis?
Colibacillosis is an intestinal disease caused by pathogenic strains of Escherichia coli, most commonly affecting young or recently weaned pigs. The disease can lead to diarrhea, dehydration, weakness, and poor growth performance. Veterinary diagnosis is important to confirm bacterial involvement and guide appropriate treatment and control measures.
